"You differ even more from the other exotics," Diya responds evenly, unperturbed by his glare. She finds Tarn's lack of subtlety ultimately disappointing. "As I said, it is a matter of application of resources. We barely have any data on the first round still. Any number of complications could arise from such disparate gene therapy."